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Comment

The large randomised controlled trial on the effect of
antibiotics to prevent infection after operative vaginal
delivery by Marian Knight and colleagues1 in The Lancet
is practice changing. Operative vaginal deliveries include
either vacuum or forceps, and are used in about 2–15% of
births.2 Even if one conservatively estimates 2% of babies
are born by operative vaginal delivery globally, about
2 700 000 of the world’s 135 million annual births are
operative vaginal deliveries. Up to 16% of these births
can be associated with infection without antibiotics
prophylaxis,3 repre
senting about 432 000 annual
infections associated with operative vaginal delivery
worldwide.
The most common infections increased with operative
vaginal delivery compared with spontaneous vaginal
delivery, include endometritis, perineal wound, and
urinary tract infections—all of which, in rare cases, can lead
to sepsis.3 Compared with spontaneous vaginal delivery,
operative vaginal delivery can introduce microorganisms
into the genital tract, is associated with longer labour,
more vaginal examinations, with bladder catheterisation
before the procedure, and with more perineal lacerations
and use of episiotomy, all of which can increase the risk of
infections. These infections can occur even after discharge,
and the risk peaks at about 6–7 days post partum.3 The
incidence of infections is higher with forceps than with
vacuum. Episiotomy also increases the risk of perineal
infections compared with no episiotomy,4 possibly
also because of the association with more and worse
perineal lacerations.5 Unfortunately, the evidence on the
effect of technical characteristics of the repair of perineal
lacerations or episiotomies, or both, on perineal infections
is scarce.6,7 Perineal infections are associated with wound
dehiscence, need for repair, and perineal pain, and
influence women’s quality of life and sexual wellbeing.3
In Knight and colleagues’ study,1 3427 women with
mostly singleton gestations at 36 weeks or later were
randomly assigned to receive either amoxicillin 1 g
and clavulanic acid 200 mg or placebo within 6 h of
operative vaginal delivery. The primary outcome,
confirmed or suspected maternal infection within
6 weeks of delivery, was defined by one of the following:
a new prescription of antibiotics for presumed perineal
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wound-related infection, endo
metritis or uterine
infection, urinary tract infection with systemic features
(pyelonephritis or sepsis), or other systemic infection
(clinical sepsis); confirmed systemic infection on culture;
or endometritis. This primary outcome was significantly
less common in the antibiotic (11%) versus the placebo
(19%) group (risk ratio [RR] 0·58, 95% CI 0·49–0·69).
The incidences of perineal infection, perineal pain,
use of pain relief for perineal pain, need for additional
perineal care, wound breakdown, perineum ever too
uncomfortable to feed the baby, and any visits in
relation to perineal concerns were all each statistically
significantly decreased in the antibiotics group
compared with placebo. The primary outcome was
more common in forceps versus vacuum deliveries, but
the magnitude of the beneficial effect of the antibiotic
versus placebo was similar (forceps 13% vs 22%, RR 0·62,
95% CI 0·45–0·86, respectively; vacuum 8% vs 14%,
RR 0·56, 95% CI 0·39–0·80, respectively).
The main strengths of this study are that it is large,
methologically well done, covers an important clinical
issue, and is practice changing. Only one small study8 had
been previously done on this issue. Other strengths are
the use of only one dose of antibiotics, limiting the effect
on microbiota of both mother and baby (effect through
breastfeeding). Risks of negative effects on the baby, such
as necrotising enterocolitis or asthma,3 can be minimised
if the antibiotic is given after delivery, and this antibiotic
has been shown to be safe for infant breastfeeding.9
The main limitation of the study is the primary
outcome, which was driven mostly by a new prescription
for antibiotics for presumed perineal infection. Although
the trial was blinded, the prescribing of antibiotics is
more subjective than culture-proven infection. The
study shows that the results for the cumulative primary
outcome are the same as those for new prescription
for antibiotics for presumed perineal infection. The
criteria used by practitioners to decide to whom to give
antibiotics was unclear. Nonetheless, confirmed cultureproven sepsis was significantly less in the amoxicillin
and clavulanic acid group than in the placebo group
(0·6% vs 1·5%, respectively; RR 0·44, 95% CI 0·22–0·89).
The timing of antibiotics was 3·2 h after delivery, which is
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late; in practice, administration of the antibiotic intrave
nously right after delivery would be feasible. Indeed,
prophylaxis for caesarean section is more effective when
given before skin incision than after cord clamping.
The choice of antibiotics is debatable, but Knight and
colleagues have made a good case for their choice of
amoxicillin and clavulanic acid.3 Another limitation of
the study is that women with third-degree and fourthdegree lacerations were excluded because they get
antibiotics anyway.10 The majority (89%) of women
enrolled had an episiotomy—a proportion that is too
high, even for operative vaginal delivery, as admitted
by authors. Unfortunately, a subgroup analysis for just
those women without an episiotomy is not available.
Moreover, neonatal outcomes are not reported; although
the antibiotic was given after birth, it is secreted in
breastmilk, and could affect neonates. Another potential
issue is the development of antibiotic resistance.
More emphasis should be placed on prevention of
perineal trauma, and therefore perineal infection, in
future research. The use of perineal massage11 and warm
compresses to the perineum12 in the second stage of
labour have each been associated with a significant
decrease in perineal trauma. Clinical guidelines should
be updated to reflect the new recommendation of
giving a single dose of intravenous amoxicillin and
clavulanic acid within 6 h after operative vaginal
delivery, in particular to women who also have an
episiotomy. More research is needed for operative
vaginal deliveries not necessitating an episiotomy.
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Renal cell carcinoma is one of the most common
urological cancers and its incidence is on the rise.1
Outcomes for patients with advanced renal cell carcinoma
have improved substantially with the advent of vascular
endothelial growth factor (VEGF)-targeted drugs, and
with the approval of immune checkpoint blocking
antibodies in the past 4 years.2 Although each of these
drug classes has shown single drug efficacy, responses
remain transient for most patients, culminating in a
high proportion of patients eventually having disease
progression or death.2
Angiogenesis and immunosuppression are hallmarks
of cancer that allow for tumour cell growth and

survival, and preclinical and early phase clinical data
have shown these two pathways to be linked.3–5
Targeting VEGF and its receptors results in increased
T-cell priming and infiltration; however, targeting
also induces interferon gamma-mediated counterregulatory programmed death-ligand 1 (PD-L1)
upregulation, and T-cell exhaus
tion.3,5 Furthermore,
PD-L1 expression predicts for worse outcomes after
treatment with antiangiogenic drugs in patients
with renal cell carcinoma.6,7 Thus, the combination
of antiangiogenic and immune checkpoint
blocking drugs, which allows a newly inflamed
tumour microenvironment to effectively eradicate
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